RE DeGryse
Impact in
- Psychiatry and Mental health top 0.5%
- Migraine and Headache Studies
-
- Trigeminal Neuralgia and Treatments
- Ophthalmology and Eye Disorders
Papers in
-
- Migraine and Headache Studies 9
-
- Ophthalmology and Eye Disorders 3
- Trigeminal Neuralgia and Treatments 2
- Co-authors
- CC Turkel (9 shared papers)DW Dodick (9 shared papers)SD Silberstein (3 shared papers)RB Lipton (2 shared papers)HC Diener (3 shared papers)SK Aurora (4 shared papers)Richard B. Lipton (1 shared paper)Isaac Willis (1 shared paper)
- Journals
- The Journal of Headache and Pain (7 papers)Cephalalgia (2 papers)Clinical Drug Investigation (1 paper)
- Partner nations
- United StatesGermanyIreland
In The Last Decade
RE DeGryse
10 papers receiving 1.4k citations
RE DeGryse's Hit Papers
Peers
Comparison fields: 5 of 39
- Psychiatry and Mental health 1.3k
- Pathology and Forensic Medicine 581
- Neurology 374
- Physiology 520
- Complementary and Manual Therapy 19
Countries citing papers authored by RE DeGryse
This map shows the geographic impact of RE DeGryse's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by RE DeGryse with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites RE DeGryse more than expected).
Fields of papers citing papers by RE DeGryse
This network shows the impact of papers produced by RE DeGryse. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by RE DeGryse. The network helps show where RE DeGryse may publish in the future.
Co-authors
The 9 scholars most cited alongside RE DeGryse, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | OnabotulinumtoxinA for treatment of chronic migraine: Results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial Hit paper breakdown → | 2010 | 787 |
| 2 | OnabotulinumtoxinA for treatment of chronic migraine: Results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial Hit paper breakdown → | 2010 | 721 |
| 3 | 1991 | 4 | |
| 4 | 2013 | 4 | |
| 5 | 2013 | 3 | |
| 6 | 2013 | 1 | |
| 7 | 2013 | 1 | |
| 8 | 2013 | 1 | |
| 9 | 2013 | 1 | |
| 10 | 2013 | 1 |
About RE DeGryse
RE DeGryse is a scholar working on Psychiatry and Mental health, Pathology and Forensic Medicine, Neurology, Surgery and Epidemiology, having authored 10 papers that have together received 1.5k indexed citations. Recurring topics across this work include Migraine and Headache Studies (9 papers), Botulinum Toxin and Related Neurological Disorders (5 papers), Ophthalmology and Eye Disorders (3 papers), Trigeminal Neuralgia and Treatments (2 papers), Sympathectomy and Hyperhidrosis Treatments (1 paper), Nail Diseases and Treatments (1 paper) and Cardiovascular Syncope and Autonomic Disorders (1 paper). The work is most often cited by research in Psychiatry and Mental health (1.3k citations), Pathology and Forensic Medicine (581 citations), Neurology (374 citations), Physiology (520 citations) and Complementary and Manual Therapy (19 citations). RE DeGryse has collaborated with scholars based in United States, Germany and Ireland. Frequent co-authors include CC Turkel, DW Dodick, SD Silberstein, RB Lipton, HC Diener, SK Aurora, Richard B. Lipton, Isaac Willis and HC Diener. Their work appears in journals such as The Journal of Headache and Pain, Cephalalgia and Clinical Drug Investigation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.